Save the date for the GIDWG Public and Industry Meeting!

by

Stay tuned for the 6th Annual GIDWG Public and Industry Meeting, generously hosted by the Thai Food and Drug Administration on 22 October 2026, tentatively from 08:00 to 12:00 ICT.

The meeting is open to all participants interested in IDMP and its global implementation. Streaming live from Bangkok, Thailand, the session will feature updates from the stakeholder meeting’s technical discussions, showcase use cases, and highlight progress in the global implementation of ISO IDMP by GIDWG members from both regulatory authorities and the pharmaceutical industry.

Registration for online attendees will open on the GIDWG website in late September.

The GIDWG Public and Industry Meeting will be streaming via Zoom.

October 2025: The 5th Global IDMP Working Group Public Day meeting hosted at the European Medicines Agency in Amsterdam, the Netherlands

by

Our previous meetings have consistently delivered insightful and valuable content. We are pleased to welcome you to the 5th Global IDMP Working Group (GIDWG) Stakeholder Public Day Meeting, scheduled for 3 October 2025, and graciously hosted by the European Medicines Agency in Amsterdam, the Netherlands.

Presentation materials:

GIDWG Public Day meeting 3 Oct 2025Download

Invitation to the GIDWG Stakeholder Public meeting

by

The Global IDMP Working Group (GIDWG), is pleased to invite you to an online public meeting, streaming live from the European Medicines Agency (EMA) on Friday 3th October 2025 at 12:30 to 14:00 CEST via Zoom.

This year’s GIDWG Stakeholder Public Meeting will present important updates and insights from the Global IDMP Working Group. The co-chairs will highlight  key takeaways from the recent technical meeting, followed by contributions from GIDWG members  showcasing their involvement in IDMP and use case opportunities for Global PhPID Services

All interested stakeholders are welcome to attend the meeting and engage with this pivotal effort to strengthen global medicinal product data standards.

To register, please visit https://who-umc-org.zoom.us/webinar/register/WN_XTv5y_HpSUmDya9Z5TwodA

September 2024: Global IDMP Working Group (GIDWG) yearly stakeholders’ meeting at Brazilian Health Regulatory Agency

by

Our past conferences have been full of valuable information and great networking opportunities. We expect this year to be the same. Welcome to our 4th Global IDMP Working Group (GIDWG) Stakeholder Meeting, planned for the third week of September 2024, hosted by the Brazilian Health Regulatory Agency (Anvisa) in Brazil.

UPDATE: Thank you to everyone who attended the 4th GIDWG Technical and Stakeholder Meeting for making it such a success. It provided an excellent platform to further our shared vision of global IDMP implementation.

Presentations materials:

GIDWG Regulator and Industry Forums 11 SEP 2024Download
GIDWG Public Meeting 12 SEP 2024Download

End-to-end demonstration Q4 2023–Q2 2024

by

Testing of use cases for PhPID operating model

PURPOSE

To test the framework, including business rules, best practices, software, and operating model, for global IDMP implementation and maintenance of global identifiers for marketed products.

SCOPE

• Validate and generate PhPIDs for medicinal products based on GIDWG/EWG Business Rules

• EDQM and non-EDQM countries

• Similar products from different countries

• Larger batches and smaller data sets for regulators  

• Test use cases for pharmacovigilance, drug shortages, and cross-border healthcare

STATUS

Completed

Global IDMP PhPID End-to-End Testing report, 5 December 2024

PhPID Construction for End-to-End Test Results 5Dec2024Download

18 October: Global IDMP Working Group (GIDWG) stakeholders’ public meeting

by

Welcome to our 3rd Global IDMP Working Group (GIDWG) Stakeholder Meeting.

GIDWG’s mission is to establish a framework for global implementation of ISO IDMP standards and maintenance of global identifiers.

The GIDWG will report on 5 pilot projects:

  1. Substance Identifiers
  2. Dose form Identifiers
  3. Strength Definitions Identifiers
  4. Operational Model
  5. FHIR for information exchange.

These projects cover global use cases including pharmacovigilance, drug shortages, and cross-border healthcare.

Presentation materials:

3d-Global-IDMP-Working-Group-GIDWG-Stakeholders-Public-Meeting-Day-3Download

IDMP webinar – Current status and the road to implementation 

by

Uppsala Monitoring Centre (UMC) sees IDMP as a game-changer for pharmacovigilance. It establishes a common language and enables the effective exchange of vital medicinal product data throughout the drug development and regulatory lifecycle. By standardising data exchange, IDMP improves our ability to identify, evaluate, and manage risks associated with medicinal products. In a one-hour webinar on 14 June 2023, UMC will discuss the current status of IDMP and collaboration efforts to implement the standards.

UPDATE: Recordings of the webinar are now available: